MAPT and Alzheimer disease: In the biological course of AD, increasing fractions of p-tau212-containing tau forms might be released into biofluids, including CSF and blood, which explains the association of plasma/CSF p-tau212 concentrations retrospectively measured in antemortem samples with NFT content at autopsy.